From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Group | Cohort | DMARD | Biologic | Prednisone | Joint Injection | Inactive Wallace | Inactive 1 cJADAS10 | Minimal 2 cJADAS10 |
---|---|---|---|---|---|---|---|---|
All categories | 2005-10 | 43 (40,47) | 6 (5,7) | 16 (14,18) | 43 (40,46) | 63 (60,66) | 50 (47,53) | 69 (66,72) |
2017-21 | 60 (56,64) | 26 (23,30) | 16 (13,19) | 36 (32,40) | 84 (80, 87) | 69 (65,73) | 84 (81,87) | |
Oligoarthritis | 2005-10 | 21 (18,26) | 2 (1,4) | 5 (3,7) | 56 (51,61) | 78 (74,82) | 56 (51,61) | 75 (71,79) |
2017-21 | 46 (39,52) | 10 (6,15) | 6 (3,10) | 55 (49,62) | 90 (85,93) | 73 (67,79) | 89 (85,93) | |
Polyarthritis RF negative | 2005-10 | 78 (72,84) | 6 (4,10) | 18 (13,24) | 38 (32,45) | 53 (47,60) | 46 (39,56) | 64 (58,71) |
2017-21 | 84 (76,90) | 41 (32,52) | 22 (16,31) | 29 (21,39) | 86 (78,92) | 80 (72,87) | 88 (81,93) | |
Systemic | 2005-10 | 63 (51,75) | 18 (10,30) | 77 (66,87) | 8 (3,18) | 68 (56,79) | 62 (50,74) | 80 (69,89) |
2017-21 | 47 (29,69) | 66 (49,83) | 83 (65,95) | -- | 91 (76,98) | 78 (59,92) | 85 (67,96) |